Chuen Yan Leung
Investor, Value Partners Group
Dr. Chuen Yan Leung is Partner (Healthcare Investments) at Value Partners Group, one of Asia’s leading independent asset management firms.
His experience spans private equity, biotechnology startups, and academia, including roles as an investment professional at EQT Group, a global top-tier private equity firm, and founding scientist at Procella Therapeutics, a Sweden-based stem cell therapeutics startup.
Dr. Leung serves as Non-Executive Director of Insilico Medicine (3696.HK), Non-Executive Director of Phase Scientific, and Vice President of the Hong Kong Biotechnology Organization.
He holds a PhD in Stem Cell Biology from the University of Cambridge and a BSc in Biochemistry from Imperial College London.
His experience spans private equity, biotechnology startups, and academia, including roles as an investment professional at EQT Group, a global top-tier private equity firm, and founding scientist at Procella Therapeutics, a Sweden-based stem cell therapeutics startup.
Dr. Leung serves as Non-Executive Director of Insilico Medicine (3696.HK), Non-Executive Director of Phase Scientific, and Vice President of the Hong Kong Biotechnology Organization.
He holds a PhD in Stem Cell Biology from the University of Cambridge and a BSc in Biochemistry from Imperial College London.